Hollencrest Capital Management’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-63
Closed -$1.93K 1109
2024
Q1
$1.93K Hold
63
﹤0.01% 901
2023
Q4
$2.17K Hold
63
﹤0.01% 882
2023
Q3
$4.14K Hold
63
﹤0.01% 843
2023
Q2
$5.06K Hold
63
﹤0.01% 850
2023
Q1
$5.2K Hold
63
﹤0.01% 844
2022
Q4
$5.4K Buy
+63
New +$5.67K ﹤0.01% 814

Other funds holding DRIO

Hollencrest Capital Management's DRIO Position: Q2 2024 in Review

Hollencrest Capital Management sold out of DarioHealth (DRIO) in Q2 2024, closing a stake of 63 shares — an estimated $1.93K sold.

Hollencrest Capital Management first reported a position in DRIO in Q4 2022 and held it in 6 quarters. The position peaked at $5.4K in Q4 2022. 37 funds tracked by Wall St. Rank hold DRIO as of Q2 2024.

  • Hollencrest Capital Management reported no remaining DarioHealth position as of Q2 2024 after selling out during the quarter.
  • Hollencrest Capital Management sold 63 DarioHealth shares in Q2 2024, an estimated $1.93K.
  • Hollencrest Capital Management first reported a position in DarioHealth in Q4 2022 and held it in 6 quarters.
  • Hollencrest Capital Management's DarioHealth position peaked at $5.4K in Q4 2022.
  • 37 funds tracked by Wall St. Rank held DarioHealth as of Q2 2024.

Based on Hollencrest Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.